110 related articles for article (PubMed ID: 6533499)
1. Ovarian cancer: diagnosis using 123I monoclonal antibody in comparison with surgical findings.
Granowska M; Shepherd J; Britton KE; Ward B; Mather S; Taylor-Papadimitriou J; Epenetos AA; Carroll MJ; Nimmon CC; Hawkins LA
Nucl Med Commun; 1984 Aug; 5(8):485-99. PubMed ID: 6533499
[No Abstract] [Full Text] [Related]
2. A prospective study of 123I-labeled monoclonal antibody imaging in ovarian cancer.
Granowska M; Britton KE; Shepherd JH; Nimmon CC; Mather S; Ward B; Osborne RJ; Slevin ML
J Clin Oncol; 1986 May; 4(5):730-6. PubMed ID: 3701391
[TBL] [Abstract][Full Text] [Related]
3. The detection of ovarian cancer using 123J monoclonal antibody.
Granowska M; Britton KE; Shepherd J
Radiobiol Radiother (Berl); 1984; 25(1):153-60. PubMed ID: 6729079
[No Abstract] [Full Text] [Related]
4. [REGAJ diagnosis of recurrence of ovarian cancer].
Paterok EM; Jäger W; Feistel H; Lang N; Wolf F
Gynakol Rundsch; 1989; 29 Suppl 2():360-3. PubMed ID: 2613050
[No Abstract] [Full Text] [Related]
5. Radioimmunodiagnosis of ovarian cancer using 123I-labelled, tumor-associated monoclonal antibodies.
Epenetos AA; Shepherd J; Britton KE; Hawkins L; Nimmon CC; Taylor-Papadimitriou J; Durbin H; Malpas JS; Mather S; Granowska M
Cancer Detect Prev; 1984; 7(1):45-9. PubMed ID: 6367983
[TBL] [Abstract][Full Text] [Related]
6. 123I radioiodinated antibody imaging of occult ovarian cancer.
Epenetos AA; Shepherd J; Britton KE; Mather S; Taylor-Papadimitriou J; Granowska M; Durbin H; Nimmon CC; Hawkins LR; Malpas JS
Cancer; 1985 Mar; 55(5):984-7. PubMed ID: 3881163
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic evaluation of 111In and 99mTc radiolabelled monoclonal antibodies in ovarian and colorectal cancer: correlations with surgery.
Granowska M; Mather SJ; Britton KE
Int J Rad Appl Instrum B; 1991; 18(4):413-24. PubMed ID: 1864730
[TBL] [Abstract][Full Text] [Related]
8. OC125 immunoscintigraphy in ovarian carcinoma: a comparison with alternative methods of assessment.
Maughan TS; Haylock B; Hayward M; Facey P; Evans WD; Shelley MD; Fish RG; Adams M
Clin Oncol (R Coll Radiol); 1990 Jul; 2(4):199-205. PubMed ID: 2261415
[TBL] [Abstract][Full Text] [Related]
9. Radionuclide imaging of epithelial ovarian tumours with 123I-labelled monoclonal antibody (H317) specific for placental-type alkaline phosphatase.
Critchley M; Brownless S; Patten M; McLaughlin PJ; Tromans PM; McDicken IW; Johnson PM
Clin Radiol; 1986 Mar; 37(2):107-12. PubMed ID: 3698490
[TBL] [Abstract][Full Text] [Related]
10. [Immunoscintigraphy, an aid to the oncologist--the Rennes experience in using anti-CEA, anti-CA 19.9 monoclonal antibodies and radiolabelled OC-125].
Herry JY; Bourguet P; Kerbrat P; Le Prise E; Ben Hassel M; Gedouin D; Richier JL
Allerg Immunol (Paris); 1987 May; 19(5):180-8. PubMed ID: 3330945
[TBL] [Abstract][Full Text] [Related]
11. Radionuclide imaging of ovarian tumours with a radiolabelled (123I) monoclonal antibody (NDOG2).
Jackson PC; Pitcher EM; Davies JO; Davies ER; Sadowski CS; Staddon GE; Stirrat GM; Sunderland CA
Eur J Nucl Med; 1985; 11(1):22-8. PubMed ID: 4043110
[TBL] [Abstract][Full Text] [Related]
12. [The detection of metastases of ovarian carcinoma by immunoscintigraphy with monoclonal antibodies].
Peking A; Marinov V
Akush Ginekol (Sofiia); 1990; 29(1):57-60. PubMed ID: 2164792
[TBL] [Abstract][Full Text] [Related]
13. Antibody-guided radiolocalisation of tumours in patients with testicular or ovarian cancer using two radioiodinated monoclonal antibodies to placental alkaline phosphatase.
Epenetos AA; Carr D; Johnson PM; Bodmer WF; Lavender JP
Br J Radiol; 1986 Feb; 59(698):117-25. PubMed ID: 3947819
[TBL] [Abstract][Full Text] [Related]
14. [Immunoscintigraphy of cancer of the ovaries and colon using labeled monoclonal antibodies].
Gabuniia RI; Shiriaev SV; Bogdasarov IuB; Zhordaniia KI; Anan'ev VS
Med Radiol (Mosk); 1989 Aug; 34(8):56-61. PubMed ID: 2770446
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies in ovarian tumor imaging.
Fotiou S; Skarlos D; Tserkezoglou A; Aravantinos G; Malamitsi J; Koutoulidis K
Eur J Gynaecol Oncol; 1988; 9(4):304-7. PubMed ID: 3391206
[TBL] [Abstract][Full Text] [Related]
16. Strategies for the development of monoclonal antibodies for in vivo imaging: their use in the imaging of ovarian carcinoma.
Burchell J; Taylor-Papadimitriou J; Griffiths AB
Cancer Detect Prev Suppl; 1987; 1():241-7. PubMed ID: 3480054
[TBL] [Abstract][Full Text] [Related]
17. Primary diagnosis and follow-up of ovarian cancer: radioimmunoscintigraphy with iodine-131 labeled OC 125 monoclonal antibodies versus computed tomography and "second look".
Barzen G; Hierholzer J; Cordes M; Friedmann W; Felix R
Int J Rad Appl Instrum B; 1991; 18(1):69-76. PubMed ID: 2010310
[No Abstract] [Full Text] [Related]
18. Immunoscintigraphy in the follow up of patients with ovarian cancer.
Gerli M; Palumbo R; Angelini A; Gerli S; Brunelli E; Pupita P; Bonaca S; Spagnolo W
Eur J Gynaecol Oncol; 1990; 11(3):203-4. PubMed ID: 2209638
[TBL] [Abstract][Full Text] [Related]
19. The use of radiolabelled monoclonal antibodies to human milk fat globule membrane antigens in antibody-guided tumour imaging, and administration of therapeutic dose of labelled antibody in wide-spread ovarian carcinoma. A preliminary report.
Ashorn R; Ashorn P; Punnonen R; Pöyhönen L; Turjanmaa V; Koskinen M; Helle M; Uusitalo A; Pystynen P; Krohn K
Ann Chir Gynaecol Suppl; 1985; 197():5-10. PubMed ID: 3863532
[TBL] [Abstract][Full Text] [Related]
20. [Immunoscintigraphy of oncologic tumors].
Barzen G
Radiol Diagn (Berl); 1990; 31(3):209-20. PubMed ID: 2367627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
